Mankind Pharma's consolidated profit after tax rose 10% YoY to Rs 543 crore in the April-June quarter, driven by increased revenue. Read more.
Photograph: Courtesy, Mankind Pharma
New Delhi, Jul 31 (PTI) Mankind Pharma on Wednesday said its consolidated profit after tax increased by 10 per cent year on year to Rs 543 crore in the quarter ended on June 30, 2024.
The drug firm had reported a profit after tax of Rs 494 crore in the April-June quarter of the previous fiscal.
Revenue from operations rose to Rs 2,893 crore in the period under review from Rs 2,579 crore in the year-ago period, Mankind Pharma said in a statement.
Shares of the company on Wednesday ended 1.21 per cent down at Rs 2,031.15 apiece on the BSE.
Home » Market News » Mankind Pharma Profit Up 10% to Rs 543 cr in Q1 FY25
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback